Stan Riddell, Fred Hutch cancer immunotherapy innovator, to present at AAAS Annual Meeting

Dr. Stanley Riddell, an immunotherapy researcher and oncologist at Seattle’s Fred Hutchinson Cancer Research Center, will present an update on new adoptive T-cell strategies for cancer at the AAAS annual meeting Feb. 14. His presentation will be part of a symposium on the promise and progress of T-cell therapy to fight human diseases. For more than 25 years, Riddell has pioneered experimental therapies that modify and empower the immune system to effectively treat cancers and infectious diseases. —> Read More